@article{2996893,
    title = "Intravenous thrombolysis for acute ischemic stroke in COVID-19 era: Still the same?",
    author = "Bakola, E. and Giannopoulos, S.",
    journal = "Acta Neurologica Scandinavica",
    year = "2022",
    volume = "145",
    number = "2",
    pages = "125-126",
    publisher = "John Wiley and Sons Inc",
    issn = "0001-6314, 1600-0404",
    doi = "10.1111/ane.13545",
    keywords = "fibrinolytic agent;  fibrinolytic agent;  tissue plasminogen activator, acute ischemic stroke;  brain ischemia;  coronavirus disease 2019;  Editorial;  fibrinolytic therapy;  functional status;  hospitalization;  human;  mechanical thrombectomy;  National Institutes of Health Stroke Scale;  pandemic;  reperfusion;  brain ischemia;  cerebrovascular accident;  complication;  fibrinolytic therapy;  treatment outcome, Brain Ischemia;  COVID-19;  Fibrinolytic Agents;  Humans;  Ischemic Stroke;  SARS-CoV-2;  Stroke;  Thrombolytic Therapy;  Tissue Plasminogen Activator;  Treatment Outcome"
}